Dr. Reddy's Laboratories’ wholly-owned subsidiary -- Dr Reddy's Laboratories Inc and Ingenus Pharmaceuticals, LLC have entered into license agreement. Subsequently, Dr Reddy's Laboratories Inc (Dr Reddy's USA) has licensed from Ingenus, the exclusive rights to commercialise Cyclophosphamide injection of strengths 500 mg/2.5mL; 1g/5mL; 2g/10mL in the US.
Under the in-licensing pact, Dr Reddy's USA will commercialise the Cyclophosphamide injection for the US market and will pay Ingenus 50 per cent of the calculated profit share and no other consideration is payable.
The sales of the said Ingenus product as per the IQVIA for the past 12 months ended March 2024 was $51.8 million. The parties will enter into a commercial supply agreement pursuant to which Ingenus will supply the product to Dr Reddy's USA.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |